financetom
Business
financetom
/
Business
/
Crown Point Energy Announcing Placement of US$30 Million of Series IX Notes
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Crown Point Energy Announcing Placement of US$30 Million of Series IX Notes
Mar 11, 2026 2:29 AM

07:31 AM EST, 02/02/2026 (MT Newswires) -- Crown Point Energy ( CWVLF ) over the weekend said that its wholly-owned Argentine subsidiary, Crown Point Energia S.A. (CPE), issued a total of US$30 million principal amount of Series IX secured fixed-rate notes, which are denominated in US$ and payable in Pesos (Argentine pesos).

The company said that the payment for the Series IX notes consisted of around US$24.6 million principal amount of Series IX Notes issued for cash consideration, payable in Pesos.

It also included around US$5.4 million principal amount of Series IX Notes issued in exchange for the surrender and cancellation of around US$5.4 million principal amount of Series V notes of the company at an exchange ratio of US$100 principal amount of Series IX Notes for every US$100 principal amount of Series V Notes.

The company said that the total principal amount of the Series IX Notes will be repaid in ten equal installments starting on Oct. 30, 2026, and the last installment will be payable on Jan. 30, 2029.

It added that the Series IX Notes accrue interest at a fixed rate of 10.75% per annum, payable every three months in arrears from the issue date.

In a statement the company noted that the Series IX Notes are guaranteed with a pledge on crude oil sales collections from the El Tordillo, Puesto Quiroga and La Tapera concessions.

The net proceeds will be used for general corporate purposes and to make investments in the development of assets in Argentina.

The company added that the offering was made pursuant to CPE's Negotiable Obligations Issuance Global Program for up to US$300 million (or its equivalent in other currencies or units of value) established by CPE's base prospectus dated June 18, 2025, as amended on Nov. 4, 2025 and supplemented by prospectus supplement dated Jan. 23, 2026.

The company further stated that, following the closing of the offering, CPE has notes outstanding of around US$1.8 million principal amount of Series V Notes, US$22 million principal amount of Series VI Notes, US$25 million principal amount of Series VII Notes and US$30 million principal amount of Series IX Notes.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved